START FREE TRIAL

Alphabet Joins $4 Trillion Club, But Can Gemini Match ChatGPT Health & Copilot?

AI Summary

🔒 UNLOCK AI SUMMARY WITH FREE TRIAL

START FREE TRIAL

Alphabet (NASDAQ:GOOGL) just closed above a $4 trillion market cap for the first time, a symbolic and financial milestone that cements its place alongside Apple, Microsoft, and Nvidia at the summit of global tech. The stock rose 66% in 2025, powered by a wave of optimism around its Gemini AI models and an unexpected alliance with Apple—where Gemini now underpins Apple’s next-gen “Apple Intelligence” system. Yet, as Alphabet joins the $4 trillion club, a new AI frontier is opening in healthcare. OpenAI has launched ChatGPT Health, while Microsoft is integrating Harvard Medical data into its Copilot assistant. Both are positioning themselves at the intersection of AI and human well-being—a space Google once pioneered but now seems hesitant to dominate. So, is Alphabet’s Gemini falling behind in healthcare AI? And can the momentum behind this $4 trillion milestone sustain itself?

Distribution Via Apple–Gemini & Default Placement

Alphabet joins $4 trillion club largely because of one major tailwind: distribution. The partnership with Apple ensures that Gemini, Google’s generative AI engine, powers…

Continue Reading With Our 7-Day Free Trial

ONLY $10 per month after the trial. Cancel anytime. No sponsors. No conflicts. 100% independent stock research.

Recent Articles

Oracle’s Earnings “Disaster” Is the BEST NEWS For The AI Infrastructure Trade!

Oracle reported after the bell last night. Here are...

Oracle Reports Tonight. The Revenue Number Is Not The Question.

Tonight at 5 PM ET, Oracle drops its fiscal...

Amazon Just Paid BILLIONS For Glass. The AI Bottleneck NOBODY Is Talking About!

On Monday, Amazon announced a multiyear, multibillion-dollar agreement with...

Did Ingredion Find A Mispriced Path Into Higher-Value Ingredients?

Ingredion (NYSE:INGR) has moved into deal mode with a...

Incyte Acquisition Watch: The $2 Billion Star Therapeutics Deal That Could Change Its Story

Incyte Corporation (NASDAQ:INCY) is back in the biotech deal...

Related Articles

Amazon Just Paid BILLIONS For Glass. The AI Bottleneck NOBODY Is Talking About!

On Monday, Amazon announced a multiyear, multibillion-dollar agreement with...

Did Ingredion Find A Mispriced Path Into Higher-Value Ingredients?

Ingredion (NYSE:INGR) has moved into deal mode with a...

Incyte Acquisition Watch: The $2 Billion Star Therapeutics Deal That Could Change Its Story

Incyte Corporation (NASDAQ:INCY) is back in the biotech deal...

Broadcom Said 3 Words That Killed The Narrative: “WE ARE CHIPS ONLY!”A

Let's do the math quickly. Broadcom (NASDAQ:AVGO) just reported $10.8...
spot_img

Related Articles

Popular Categories

spot_imgspot_img